• Markets
• News
• Learn

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Wedbush raised the price target for Replimune Group Inc (NASDAQ:REPL) from $6 to $9. Wedbush analyst Robert Driscoll maintained a Neutral rating. Replimune shares closed at $11.20 on Monday. See how other analysts view this stock.
• Canaccord Genuity cut Strategy Inc (NASDAQ:MSTR) price target from $163 to $130. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating. Strategy shares closed at $92.68 on Monday. See how other analysts view this stock.
• Barclays raised price target for Watts Water Technologies Inc (NYSE:WTS) from $317 to $414. Barclays analyst William Grippin upgraded the stock from Equal-Weight to Overweight. Watts Water Technologies shares closed at $358.93 on Monday. See how other analysts view this stock.
• Rosenblatt boosted the price target for Comcast Corp (NASDAQ:CMCSA) from $24 to $31. Rosenblatt analyst Barton Crockett upgraded the stock from Neutral to Buy. Comcast shares closed at $24.22 on Monday. See how other analysts view this stock.
• Goldman Sachs increased State Street Corp (NYSE:STT) price target from $168 to $194. Goldman Sachs analyst Alexander Blostein maintained a Buy rating. State Street shares closed at $170.18 on Monday. See how other analysts view this stock.
• Evercore ISI Group raised Owens Corning (NYSE:OC) price target from $139 to $188. Evercore ISI Group analyst Stephen Kim upgraded the stock from In-Line to Outperform. Owens Corning shares closed at $156.05 on Monday. See how other analysts view this stock.
• Cantor Fitzgerald boosted BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) price target from $27 to $29. Cantor Fitzgerald analyst Steven Seedhouse maintained an Overweight rating. BioCryst Pharmaceuticals shares closed at $9.55 on Monday. See how other analysts view this stock.
• BTIG boosted the price target for Edwards Lifesciences Corp (NYSE:EW) from $100 to $110. BTIG analyst Marie Thibault maintained a Buy rating. Edwards Lifesciences shares closed at $91.18 on Monday. See how other analysts view this stock.
• Baird increased Taysha Gene Therapies Inc (NASDAQ:TSHA) price target from $12 to $15. Baird analyst Jack Allen maintained an Outperform rating. Taysha Gene Therapies shares closed at $6.73 on Monday. See how other analysts view this stock.
• Argus Research raised Darden Restaurants Inc (NYSE:DRI) price target from $240 to $245. Argus Research analyst John Staszak maintained a Buy rating. Darden shares closed at $205.70 on Monday. See how other analysts view this stock.

Considering buying DRI stock? Here’s what analysts think:

Photo via Shutterstock